A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Generalized Anxiety Disease

Interventions

DRUG

Lithium

300 mg lithium, oral, once initially and then again at day 4 of PD 0332334 treatment

DRUG

PD 0332334

225 mg q12h PD 0332334, oral, 9 days treatment

DRUG

Lithium

300 mg lithium, oral, at day 4 of PD 0332334 treatment and after 7 day washout

DRUG

PD 0332334

225 mg q12h PD 0332334, oral, 9 days treatment